Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment
Year: 2026
Type: article
Source: Neurology
Authors: Aravind Ganesh, Eric E. Smith, Jop Mostert, Eva M. Strijbis, Menno M. Schoonheim, Chenjie Xia, Yannick Nadeau, Victoria M. Leavitt, Lorraine V. Kalia, Sebastiaan Engelborghs, Miguel D'Haeseleer, Tarrant McPherson, Gary R. Cutter, Marcus Werner Koch, for Alzheimer's Disease Neuroimaging Initiative (ADNI)
Institutions: University of Calgary, Rijnstate Hospital, Amsterdam Neuroscience, Amsterdam UMC Location Vrije Universiteit Amsterdam, McGill University, Centre hospitalier universitaire de Québec, Centre hospitalier de l'Université Laval, Université Laval, Columbia University Irving Medical Center, University Health Network, University of Toronto, Krembil Research Institute, Krembil Brain Institute, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Emory University, University of Alabama at Birmingham
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7165186140